Pennant Group [PNTG] vs HCA Healthcare [HCA] Detailed Stock Comparison
Pennant Group
NASDAQ
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pennant Group wins in 2 metrics, HCA Healthcare wins in 17 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pennant Group | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.66 | 15.25 | HCA Healthcare |
| Price-to-Book Ratio | 2.56 | -201.80 | HCA Healthcare |
| Debt-to-Equity Ratio | 105.10 | -105.85 | HCA Healthcare |
| PEG Ratio | 20.87 | 14.79 | HCA Healthcare |
| EV/EBITDA | 22.81 | 9.31 | HCA Healthcare |
| Profit Margin (TTM) | 3.40% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | 6.03% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | 6.03% | 15.95% | HCA Healthcare |
| Return on Equity | 11.41% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | 4.00% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $30.31M | $5.64B | HCA Healthcare |
| Dividend Yield | N/A | 0.54% | N/A |
| 1-Year Return | -26.51% | 3.44% | HCA Healthcare |
| Price-to-Sales Ratio (TTM) | 1.04 | 1.20 | Pennant Group |
| Enterprise Value | $1.12B | $134.94B | HCA Healthcare |
| EV/Revenue Ratio | 1.49 | 1.86 | Pennant Group |
| Gross Profit Margin (TTM) | 14.00% | 84.91% | HCA Healthcare |
| Revenue per Share (TTM) | $23 | $293 | HCA Healthcare |
| Earnings per Share (Diluted) | $0.76 | $23.81 | HCA Healthcare |
| Beta (Stock Volatility) | 1.48 | 1.40 | HCA Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pennant Group vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pennant Group | 7.75% | 8.80% | -6.69% | -13.11% | -9.29% | -8.84% |
| HCA Healthcare | 2.21% | 5.46% | -1.49% | 3.42% | 15.92% | 25.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pennant Group | -26.51% | 27.42% | -37.73% | 39.13% | 39.13% | 39.13% |
| HCA Healthcare | 3.44% | 70.56% | 177.71% | 308.46% | 1,099.65% | 1,099.65% |
Performance & Financial Health Analysis: Pennant Group vs HCA Healthcare
| Metric | PNTG | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $776.93M | $87.38B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 247,939 | 1,985,300 |
| 90 Day Avg. Volume | 306,886 | 1,508,320 |
| Last Close | $25.99 | $381.57 |
| 52 Week Range | $21.18 - $37.13 | $289.98 - $417.14 |
| % from 52W High | -30.00% | -8.53% |
| All-Time High | $69.56 (Jan 04, 2021) | $417.14 (Oct 14, 2024) |
| % from All-Time High | -62.64% | -8.53% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.06% |
| Quarterly Earnings Growth | 0.59% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.08% |
| Operating Margin (TTM) | 0.06% | 0.16% |
| Return on Equity (TTM) | 0.11% | 136.32% |
| Debt to Equity (MRQ) | 105.10 | -105.85 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.81 | $-18.16 |
| Cash per Share (MRQ) | $0.15 | $3.88 |
| Operating Cash Flow (TTM) | $17.52M | $11.93B |
| Levered Free Cash Flow (TTM) | $4.89M | $5.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.54% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Pennant Group vs HCA Healthcare
| Metric | PNTG | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.66 | 15.25 |
| Forward P/E | 20.87 | 14.79 |
| PEG Ratio | 20.87 | 14.79 |
| Price to Sales (TTM) | 1.04 | 1.20 |
| Price to Book (MRQ) | 2.56 | -201.80 |
| Market Capitalization | ||
| Market Capitalization | $776.93M | $87.38B |
| Enterprise Value | $1.12B | $134.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.49 | 1.86 |
| Enterprise to EBITDA | 22.81 | 9.31 |
| Risk & Other Metrics | ||
| Beta | 1.48 | 1.40 |
| Book Value per Share (MRQ) | $8.81 | $-18.16 |
Financial Statements Comparison: Pennant Group vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PNTG | HCA |
|---|---|---|
| Revenue/Sales | $209.84M | $18.61B |
| Cost of Goods Sold | $180.46M | $10.98B |
| Gross Profit | $29.38M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $12.65M | $2.97B |
| EBITDA | $14.47M | $3.85B |
| Pre-Tax Income | $11.38M | $2.42B |
| Income Tax | $2.85M | $524.00M |
| Net Income (Profit) | $8.52M | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PNTG | HCA |
|---|---|---|
| Cash & Equivalents | $5.22M | $1.06B |
| Total Current Assets | $123.89M | $16.26B |
| Total Current Liabilities | $87.97M | $13.63B |
| Long-Term Debt | $312.74M | $42.92B |
| Total Shareholders Equity | $323.03M | $-438.00M |
| Retained Earnings | $65.00M | $-3.16B |
| Property, Plant & Equipment | $311.61M | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PNTG | HCA |
|---|---|---|
| Operating Cash Flow | $850,000 | $2.65B |
| Capital Expenditures | $-1.96M | $-991.00M |
| Free Cash Flow | $-23.19M | $660.00M |
| Debt Repayment | $-44.00M | $-3.90B |
| Common Stock Repurchase | N/A | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | PNTG | HCA |
|---|---|---|
| Shares Short | 736,389 | 3.89M |
| Short Ratio | 2.56 | 2.67 |
| Short % of Float | 0.03% | 0.02% |
| Average Daily Volume (10 Day) | 247,939 | 1,985,300 |
| Average Daily Volume (90 Day) | 306,886 | 1,508,320 |
| Shares Outstanding | 34.37M | 249.98M |
| Float Shares | 29.85M | 169.07M |
| % Held by Insiders | 0.05% | 0.30% |
| % Held by Institutions | 0.93% | 0.66% |
Dividend Analysis & Yield Comparison: Pennant Group vs HCA Healthcare
| Metric | PNTG | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 0.54% |
| 3-Year Avg Annual Dividend | N/A | $2.29 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $6.88 |
| Ex-Dividend Date | N/A | Mar 17, 2025 |